APVO financials

Aptevo Therapeutics (APVO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

APVO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$26.31M-$27.54M-87.27
2024––-$24.60M-$24.13M-31460.61
2023––-$28.88M-$17.41M-834248.94
2022$3.11M–-$28.64M$8.03M920357.84
2021$12.29M–-$21.40M-$28.46M-3558326.18
2020$4.31M–-$27.49M-$17.75M-3065905.42